Goldline Pharmaceutical IPO GMP Today
Goldline Pharmaceutical IPO Pages
Listed
on 18 May 2026
Grey Market Premium is a pre-listing signal. Goldline Pharmaceutical has already listed, so live GMP no longer applies. Below is the historical GMP record during the issue's subscription window.
Issue Price
₹43
Listing Price
₹59
Listing Gain
+38.95%
GMP History
| Date | GMP | Est. Listing |
|---|---|---|
| 21 May 2026 | ₹15 | ₹58 |
| 20 May 2026 | ₹15 | ₹58 |
| 19 May 2026 | ₹15 | ₹58 |
| 18 May 2026 | ₹20 | ₹63 |
| 17 May 2026 | ₹20 | ₹63 |
| 16 May 2026 | ₹20 | ₹63 |
| 15 May 2026 | ₹15 | ₹58 |
| 14 May 2026 | ₹25 | ₹68 |
| 13 May 2026 | ₹18 | ₹61 |
| 12 May 2026 | ₹17 | ₹60 |
| 11 May 2026 | ₹16 | ₹59 |
Frequently Asked Questions
What is the price band of Goldline Pharmaceutical IPO?
The price band of Goldline Pharmaceutical IPO is ₹43–₹43 per share.
What is the lot size and minimum investment for Goldline Pharmaceutical IPO?
The lot size is 3000 shares. Retail investors need a minimum investment of ₹129,000 to apply.
When does Goldline Pharmaceutical IPO open and close?
Goldline Pharmaceutical IPO opens on 12 May 2026 and closes on 14 May 2026.
When will Goldline Pharmaceutical IPO be listed?
Goldline Pharmaceutical IPO is expected to list on 18 May 2026 on BSE SME.
What is the current GMP of Goldline Pharmaceutical IPO?
The latest GMP for Goldline Pharmaceutical IPO is ₹15 (premium). This suggests an estimated listing price of ₹58.